Track the 바이오톡스텍 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 바이오톡스텍 has recorded 38 insider filings. Market capitalisation: €32.3bn. The latest transaction was disclosed on 12 March 2026 (Other). Among the most active insiders: 강종구. All data is openly available.
38
Insider Decl.
n/a
Thresholds
n/a
28 ops.
Buy Volume
n/a
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,669 of 28,169 companies
44.1
score / 100
Value
67
Quality
21
FCF yld14%
Earn yld3.6%
EV/EBITDA10.1x
ROE·
Gross mgn13%
Net mgn2.5%
Debt/EBITDA6.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
BioToxTech is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for the diagnosis and treatment of diseases.